{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:14:37Z","timestamp":1789197277238,"version":"build-2803163510"},"publisher-location":"Berlin, Heidelberg","reference-count":128,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/164_2026_842","type":"book-chapter","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:59:08Z","timestamp":1789196348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the E3 Ligase Landscape: From Small Molecule to Biological Targeted Protein Degradation"],"prefix":"10.1007","author":[{"given":"Xuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xucong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,13]]},"reference":[{"issue":"24","key":"842_CR1","doi-asserted-by":"crossref","first-page":"10486","DOI":"10.1021\/jm501541j","volume":"57","author":"A Aguilar","year":"2014","unstructured":"Aguilar A, Sun W, Liu L et al (2014) Design of chemically stable, potent, and efficacious MDM2 inhibitors that exploit the retro-mannich ring-opening-cyclization reaction mechanism in spiro-oxindoles. J Med Chem 57(24):10486\u201310498","journal-title":"J Med Chem"},{"issue":"3","key":"842_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M Bekes","year":"2022","unstructured":"Bekes M, Langley DR, Crews CM (2022) PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov 21(3):181\u2013200","journal-title":"Nat Rev Drug Discov"},{"key":"842_CR3","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.707317","volume":"9","author":"A Bricelj","year":"2021","unstructured":"Bricelj A, Steinebach C, Kuchta R et al (2021) E3 ligase ligands in successful PROTACs: an overview of syntheses and linker attachment points. Front Chem 9:707317","journal-title":"Front Chem"},{"issue":"12","key":"842_CR4","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1039\/D0SC05442A","volume":"12","author":"DK Brownsey","year":"2021","unstructured":"Brownsey DK, Rowley BC, Gorobets E et al (2021) Rapid synthesis of pomalidomide-conjugates for the development of protein degrader libraries. Chem Sci 12(12):4519\u20134525","journal-title":"Chem Sci"},{"issue":"46","key":"842_CR5","doi-asserted-by":"crossref","first-page":"11463","DOI":"10.1002\/anie.201206231","volume":"51","author":"DL Buckley","year":"2012","unstructured":"Buckley DL, Gustafson JL, Van Molle I et al (2012a) Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1alpha. Angew Chem Int Ed Engl 51(46):11463\u201311467","journal-title":"Angew Chem Int Ed Engl"},{"issue":"10","key":"842_CR6","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1021\/ja209924v","volume":"134","author":"DL Buckley","year":"2012","unstructured":"Buckley DL, Van Molle I, Gareiss PC et al (2012b) Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL\/HIF-1alpha interaction. J Am Chem Soc 134(10):4465\u20134468","journal-title":"J Am Chem Soc"},{"issue":"8","key":"842_CR7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/acschembio.5b00442","volume":"10","author":"DL Buckley","year":"2015","unstructured":"Buckley DL, Raina K, Darricarrere N et al (2015) HaloPROTACS: use of small molecule PROTACs to induce degradation of HaloTag fusion proteins. ACS Chem Biol 10(8):1831\u20131837","journal-title":"ACS Chem Biol"},{"issue":"1","key":"842_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","volume":"25","author":"GM Burslem","year":"2018","unstructured":"Burslem GM, Smith BE, Lai AC et al (2018) The advantages of targeted protein degradation over inhibition: an RTK case study. Cell Chem Biol 25(1):67\u201377 e3","journal-title":"Cell Chem Biol"},{"issue":"1","key":"842_CR9","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1038\/s41467-024-50235-x","volume":"15","author":"A Chan","year":"2024","unstructured":"Chan A, Haley RM, Najar MA et al (2024) Lipid-mediated intracellular delivery of recombinant bioPROTACs for the rapid degradation of undruggable proteins. Nat Commun 15(1):5808","journal-title":"Nat Commun"},{"issue":"13","key":"842_CR10","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/D1CS00762A","volume":"51","author":"Y Chen","year":"2022","unstructured":"Chen Y, Tandon I, Heelan W et al (2022) Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation. Chem Soc Rev 51(13):5330\u20135350","journal-title":"Chem Soc Rev"},{"issue":"1","key":"842_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/acschembio.2c00797","volume":"18","author":"Q Chen","year":"2023","unstructured":"Chen Q, Liu C, Wang W et al (2023) Optimization of PROTAC ternary complex using DNA encoded library approach. ACS Chem Biol 18(1):25\u201333","journal-title":"ACS Chem Biol"},{"issue":"11","key":"842_CR12","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1007\/s11426-025-2762-0","volume":"68","author":"F Chen","year":"2025","unstructured":"Chen F, Zhan Q, Qu Q et al (2025a) Chemically synthesized phosphorylated ubiquitin unlocks parkin for activation-controlled PROTAC platforms. Sci China Chem 68(11):5881\u20135891","journal-title":"Sci China Chem"},{"key":"842_CR13","volume":"13","author":"X Chen","year":"2025","unstructured":"Chen X, Zhou J, Dong X et al (2025b) Regulatory role of E3 ubiquitin ligases in multiple myeloma: from molecular mechanisms to therapeutic strategies. Front Cell Dev Biol 13:1620097","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"842_CR14","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1038\/s41467-025-65481-w","volume":"16","author":"CG Chisholm","year":"2025","unstructured":"Chisholm CG, Bartlett R, Brown ML et al (2025) Development of a targeted BioPROTAC degrader selective for misfolded SOD1. Nat Commun 16(1):9713","journal-title":"Nat Commun"},{"issue":"2","key":"842_CR15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/jacs.0c10008","volume":"143","author":"AD Cotton","year":"2021","unstructured":"Cotton AD, Nguyen DP, Gramespacher JA et al (2021) Development of antibody-based PROTACs for the degradation of the cell-surface immune checkpoint protein PD-L1. J Am Chem Soc 143(2):593\u2013598","journal-title":"J Am Chem Soc"},{"issue":"19","key":"842_CR16","doi-asserted-by":"crossref","first-page":"e202501488","DOI":"10.1002\/anie.202501488","volume":"64","author":"J Cui","year":"2025","unstructured":"Cui J, Zheng Q, Weng Y et al (2025) Structure-guided development of chemically tailored peptide binders of RNF43\/ZNRF3 to enable versatile design of membrane protein-targeting PROTACs. Angew Chem Int Ed 64(19):e202501488","journal-title":"Angew Chem Int Ed"},{"key":"842_CR17","doi-asserted-by":"crossref","first-page":"111967","DOI":"10.1016\/j.ejmech.2019.111967","volume":"187","author":"Y Dai","year":"2020","unstructured":"Dai Y, Yue N, Gong J et al (2020) Development of cell-permeable peptide-based PROTACs targeting estrogen receptor \u03b1. Eur J Med Chem 187:111967","journal-title":"Eur J Med Chem"},{"issue":"19","key":"842_CR18","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1039\/D2CS00387B","volume":"51","author":"CJ Diehl","year":"2022","unstructured":"Diehl CJ, Ciulli A (2022) Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders. Chem Soc Rev 51(19):8216\u20138257","journal-title":"Chem Soc Rev"},{"issue":"4","key":"842_CR19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41580-022-00543-1","volume":"24","author":"I Dikic","year":"2023","unstructured":"Dikic I, Schulman BA (2023) An expanded lexicon for the ubiquitin code. Nat Rev Mol Cell Biol 24(4):273\u2013287","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"842_CR20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tips.2020.04.005","volume":"41","author":"Y Ding","year":"2020","unstructured":"Ding Y, Fei Y, Lu B (2020) Emerging new concepts of degrader technologies. Trends Pharmacol Sci 41(7):464\u2013474","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"842_CR21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41420-023-01736-z","volume":"9","author":"S Ding","year":"2023","unstructured":"Ding S, Pang X, Luo S et al (2023) Dynamic RBM47 ISGylation confers broad immunoprotection against lung injury and tumorigenesis via TSC22D3 downregulation. Cell Death Discov 9(1):430","journal-title":"Cell Death Discov"},{"issue":"15","key":"842_CR22","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1021\/acs.jmedchem.1c00895","volume":"64","author":"G Dong","year":"2021","unstructured":"Dong G, Ding Y, He S et al (2021) Molecular glues for targeted protein degradation: from serendipity to rational discovery. J Med Chem 64(15):10606\u201310620","journal-title":"J Med Chem"},{"issue":"5","key":"842_CR23","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/acs.jmedchem.0c01845","volume":"64","author":"PS Dragovich","year":"2021","unstructured":"Dragovich PS, Pillow TH, Blake RA et al (2021a) Antibody-mediated delivery of chimeric BRD4 degraders. Part 1: exploration of antibody linker, payload loading, and payload molecular properties. J Med Chem 64(5):2534\u20132575","journal-title":"J Med Chem"},{"issue":"5","key":"842_CR24","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1021\/acs.jmedchem.0c01846","volume":"64","author":"PS Dragovich","year":"2021","unstructured":"Dragovich PS, Pillow TH, Blake RA et al (2021b) Antibody-mediated delivery of chimeric BRD4 degraders. Part 2: improvement of in vitro antiproliferation activity and in vivo antitumor efficacy. J Med Chem 64(5):2576\u20132607","journal-title":"J Med Chem"},{"issue":"2","key":"842_CR25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/jacsau.4c00111","volume":"4","author":"C Duboc","year":"2024","unstructured":"Duboc C, Flitsch SL (2024) Drug discovery and development. JACS Au 4(2):276\u2013278","journal-title":"JACS Au"},{"key":"842_CR26","volume":"2020","author":"Y Fang","year":"2020","unstructured":"Fang Y, Lin S, Yang F et al (2020) Aptamer-conjugated multifunctional polymeric nanoparticles as cancer-targeted, MRI-ultrasensitive drug delivery Systems for Treatment of castration-resistant prostate cancer. Biomed Res Int 2020:9186583","journal-title":"Biomed Res Int"},{"issue":"1","key":"842_CR27","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1038\/s41467-023-42546-2","volume":"14","author":"A Fletcher","year":"2023","unstructured":"Fletcher A, Clift D, De Vries E et al (2023) A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation. Nat Commun 14(1):7093","journal-title":"Nat Commun"},{"key":"842_CR28","volume":"7","author":"J Frost","year":"2016","unstructured":"Frost J, Galdeano C, Soares P et al (2016) Potent and selective chemical probe of hypoxic signalling downstream of HIF-alpha hydroxylation via VHL inhibition. Nat Commun 7:13312","journal-title":"Nat Commun"},{"issue":"7","key":"842_CR29","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1021\/ol400399x","volume":"15","author":"L Fu","year":"2013","unstructured":"Fu L, Gribble GW (2013) Efficient and scalable synthesis of bardoxolone methyl (cddo-methyl ester). Org Lett 15(7):1622\u20131625","journal-title":"Org Lett"},{"issue":"20","key":"842_CR30","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1021\/jm5011258","volume":"57","author":"C Galdeano","year":"2014","unstructured":"Galdeano C, Gadd MS, Soares P et al (2014) Structure-guided design and optimization of small molecules targeting the protein-protein interaction between the von Hippel-Lindau (VHL) E3 ubiquitin ligase and the hypoxia inducible factor (HIF) alpha subunit with in vitro nanomolar affinities. J Med Chem 57(20):8657\u20138663","journal-title":"J Med Chem"},{"issue":"1","key":"842_CR31","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1038\/s41467-022-32050-4","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Hou B, Zhu Q et al (2022) Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy. Nat Commun 13(1):4318","journal-title":"Nat Commun"},{"issue":"1","key":"842_CR32","volume":"15","author":"J Gao","year":"2024","unstructured":"Gao J, Jiang X, Lei S et al (2024) A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy. Nat Commun 15(1):6608","journal-title":"Nat Commun"},{"issue":"1","key":"842_CR33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41587-021-01173-2","volume":"40","author":"K Garber","year":"2022","unstructured":"Garber K (2022) The PROTAC gold rush. Nat Biotechnol 40(1):12\u201316","journal-title":"Nat Biotechnol"},{"issue":"7","key":"842_CR34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1261\/rna.078721.121","volume":"27","author":"A G\u00e1zquez-Guti\u00e9rrez","year":"2021","unstructured":"G\u00e1zquez-Guti\u00e9rrez A, Witteveldt J, Heras SR et al (2021) Sensing of transposable elements by the antiviral innate immune system. RNA 27(7):735\u2013752","journal-title":"RNA"},{"issue":"12","key":"842_CR35","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.tips.2024.10.006","volume":"45","author":"J Ge","year":"2024","unstructured":"Ge J, Hsieh C-Y, Fang M et al (2024) Development of PROTACs using computational approaches. Trends Pharmacol Sci 45(12):1162\u20131174","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"842_CR36","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.chembiol.2022.05.012","volume":"29","author":"CL Geng","year":"2022","unstructured":"Geng CL, Chen JY, Song TY et al (2022) Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling. Cell Chem Biol 29(8):1260\u201372 e8","journal-title":"Cell Chem Biol"},{"issue":"1","key":"842_CR37","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70041","volume":"86","author":"A Giustini","year":"2025","unstructured":"Giustini A, Maiocchi A, Serangeli I et al (2025) An inducible neural stem progenitor cell model for testing therapeutic interventions against neurodegeneration FENIB. Drug Dev Res 86(1):e70041","journal-title":"Drug Dev Res"},{"issue":"34","key":"842_CR38","volume":"12","author":"Q Gu","year":"2025","unstructured":"Gu Q, Xue H, Liu Z et al (2025) Developing biomaterial-based mRNA delivery system for lung disease treatment. Adv Sci 12(34):e05413","journal-title":"Adv Sci"},{"issue":"14","key":"842_CR39","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1039\/D2CS00200K","volume":"51","author":"RG Guenette","year":"2022","unstructured":"Guenette RG, Yang SW, Min J et al (2022) Target and tissue selectivity of PROTAC degraders. Chem Soc Rev 51(14):5740\u20135756","journal-title":"Chem Soc Rev"},{"issue":"3","key":"842_CR40","volume":"4","author":"X Han","year":"2023","unstructured":"Han X, Sun Y (2023) PROTACs: a novel strategy for cancer drug discovery and development. MedComm (2020) 4(3):e290","journal-title":"MedComm (2020)"},{"issue":"43","key":"842_CR41","doi-asserted-by":"crossref","first-page":"23299","DOI":"10.1002\/anie.202107347","volume":"60","author":"S He","year":"2021","unstructured":"He S, Gao F, Ma J et al (2021) Aptamer-PROTAC conjugates (APCs) for tumor-specific targeting in breast cancer. Angew Chem Int Ed Engl 60(43):23299\u201323305","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"842_CR42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-022-00999-9","volume":"7","author":"M He","year":"2022","unstructured":"He M, Cao C, Ni Z et al (2022) PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). Signal Transduct Target Ther 7(1):181","journal-title":"Signal Transduct Target Ther"},{"issue":"13","key":"842_CR43","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/15384101.2015.1044176","volume":"14","author":"K Heyne","year":"2015","unstructured":"Heyne K, Heil TC, Bette B et al (2015) MDM2 binds and inhibits vitamin D receptor. Cell Cycle 14(13):2003\u20132010","journal-title":"Cell Cycle"},{"issue":"1","key":"842_CR44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1158\/0008-5472.CAN-18-2918","volume":"79","author":"J Hines","year":"2019","unstructured":"Hines J, Lartigue S, Dong H et al (2019) MDM2-recruiting PROTAC offers superior, synergistic Antiproliferative activity via simultaneous degradation of BRD4 and stabilization of p53. Cancer Res 79(1):251\u2013262","journal-title":"Cancer Res"},{"issue":"4","key":"842_CR45","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/cr.2016.31","volume":"26","author":"X Huang","year":"2016","unstructured":"Huang X, Dixit VM (2016) Drugging the undruggables: exploring the ubiquitin system for drug development. Cell Res 26(4):484\u2013498","journal-title":"Cell Res"},{"issue":"11","key":"842_CR46","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/17425247.2019.1669558","volume":"16","author":"LM Ickenstein","year":"2019","unstructured":"Ickenstein LM, Garidel P (2019) Lipid-based nanoparticle formulations for small molecules and RNA drugs. Expert Opin Drug Deliv 16(11):1205\u20131226","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"842_CR47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s42256-024-00815-9","volume":"6","author":"I Igashov","year":"2024","unstructured":"Igashov I, St\u00e4rk H, Vignac C et al (2024) Equivariant 3D-conditional diffusion model for molecular linker design. Nat Mach Intell 6(4):417\u2013427","journal-title":"Nat Mach Intell"},{"issue":"4","key":"842_CR48","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/2472555220965528","volume":"26","author":"T Ishida","year":"2021","unstructured":"Ishida T, Ciulli A (2021) E3 ligase ligands for PROTACs: how they were found and how to discover new ones. SLAS Discov 26(4):484\u2013502","journal-title":"SLAS Discov"},{"issue":"5971","key":"842_CR49","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito T, Ando H, Suzuki T et al (2010) Identification of a primary target of thalidomide teratogenicity. Science 327(5971):1345\u20131350","journal-title":"Science"},{"issue":"D1","key":"842_CR50","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L et al (2025) Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res 53(D1):D1670\u2013D1676","journal-title":"Nucleic Acids Res"},{"key":"842_CR51","volume":"5","author":"SM Kale","year":"2015","unstructured":"Kale SM, Jaganathan D, Ruperao P et al (2015) Prioritization of candidate genes in \u201cQTL-hotspot\u201d region for drought tolerance in chickpea (Cicer arietinum L.). Sci Rep 5:15296","journal-title":"Sci Rep"},{"issue":"5","key":"842_CR52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tips.2020.02.006","volume":"41","author":"M Kostic","year":"2020","unstructured":"Kostic M, Jones LH (2020) Critical assessment of targeted protein degradation as a research tool and pharmacological modality. Trends Pharmacol Sci 41(5):305\u2013317","journal-title":"Trends Pharmacol Sci"},{"issue":"6168","key":"842_CR53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kronke","year":"2014","unstructured":"Kronke J, Udeshi ND, Narla A et al (2014) Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343(6168):301\u2013305","journal-title":"Science"},{"issue":"43","key":"842_CR54","doi-asserted-by":"crossref","first-page":"23327","DOI":"10.1002\/anie.202109237","volume":"60","author":"RP Law","year":"2021","unstructured":"Law RP, Nunes J, Chung CW et al (2021) Discovery and characterisation of highly cooperative FAK-degrading PROTACs. Angew Chem Int Ed Engl 60(43):23327\u201323334","journal-title":"Angew Chem Int Ed Engl"},{"issue":"12","key":"842_CR55","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","volume":"51","author":"K Li","year":"2022","unstructured":"Li K, Crews CM (2022) PROTACs: past, present and future. Chem Soc Rev 51(12):5214\u20135236","journal-title":"Chem Soc Rev"},{"issue":"2","key":"842_CR56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1021\/acs.jmedchem.8b00909","volume":"62","author":"Y Li","year":"2019","unstructured":"Li Y, Yang J, Aguilar A et al (2019) Discovery of MD-224 as a first-in-class, highly potent, and efficacious proteolysis targeting chimera murine double minute 2 degrader capable of achieving complete and durable tumor regression. J Med Chem 62(2):448\u2013466","journal-title":"J Med Chem"},{"issue":"6","key":"842_CR57","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.apsb.2023.01.014","volume":"13","author":"P Li","year":"2023","unstructured":"Li P, Jia C, Fan Z et al (2023) Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations. Acta Pharm Sin B 13(6):2715\u20132735","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"842_CR58","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1021\/jacs.4c16438","volume":"147","author":"S Li","year":"2025","unstructured":"Li S, Zeng T, Wu Z et al (2025) DNA tetrahedron-driven multivalent proteolysis-targeting chimeras: enhancing protein degradation efficiency and tumor targeting. J Am Chem Soc 147(2):2168\u20132181","journal-title":"J Am Chem Soc"},{"issue":"17","key":"842_CR59","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.7150\/thno.62686","volume":"11","author":"J Lin","year":"2021","unstructured":"Lin J, Jin J, Shen Y et al (2021) Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins. Theranostics 11(17):8337\u20138349","journal-title":"Theranostics"},{"key":"842_CR60","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/sigtrans.2016.24","volume":"1","author":"X Liu","year":"2016","unstructured":"Liu X, Yao Y, Ding H et al (2016) USP21 deubiquitylates Nanog to regulate protein stability and stem cell pluripotency. Signal Transduct Target Ther 1:16024","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"842_CR61","doi-asserted-by":"crossref","first-page":"eaay5154","DOI":"10.1126\/sciadv.aay5154","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu J, Chen H, Ma L et al (2020) Light-induced control of protein destruction by opto-PROTAC. Sci Adv 6(8):eaay5154","journal-title":"Sci Adv"},{"issue":"1","key":"842_CR62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","volume":"32","author":"J Liu","year":"2022","unstructured":"Liu J, Peng Y, Wei W (2022) Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends Cell Biol 32(1):30\u201344","journal-title":"Trends Cell Biol"},{"issue":"1","key":"842_CR63","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1038\/s41467-023-42233-2","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yang J, Wang T et al (2023) Expanding PROTACtable genome universe of E3 ligases. Nat Commun 14(1):6509","journal-title":"Nat Commun"},{"issue":"6168","key":"842_CR64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","volume":"343","author":"G Lu","year":"2014","unstructured":"Lu G, Middleton RE, Sun H et al (2014) The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343(6168):305\u2013309","journal-title":"Science"},{"issue":"22","key":"842_CR65","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1039\/D2CS00362G","volume":"51","author":"D Lu","year":"2022","unstructured":"Lu D, Yu X, Lin H et al (2022) Applications of covalent chemistry in targeted protein degradation. Chem Soc Rev 51(22):9243\u20139261","journal-title":"Chem Soc Rev"},{"issue":"4","key":"842_CR66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.chembiol.2021.01.005","volume":"28","author":"M Luo","year":"2021","unstructured":"Luo M, Spradlin JN, Boike L et al (2021) Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function. Cell Chem Biol 28(4):559\u201366 e15","journal-title":"Cell Chem Biol"},{"issue":"3","key":"842_CR67","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1021\/jacs.2c09129","volume":"145","author":"D Ma","year":"2023","unstructured":"Ma D, Yuan Q, Peng F et al (2023) Engineered PROTAC-CID systems for mammalian inducible gene regulation. J Am Chem Soc 145(3):1593\u20131606","journal-title":"J Am Chem Soc"},{"key":"842_CR68","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.actbio.2025.02.012","volume":"195","author":"J Ma","year":"2025","unstructured":"Ma J, Zhu R, Li M et al (2025) Proteolysis-targeting chimera-doxorubicin conjugate nanoassemblies for dual treatment of EGFR-TKI sensitive and resistant non-small cell lung cancer. Acta Biomater 195:421\u2013435","journal-title":"Acta Biomater"},{"key":"842_CR69","doi-asserted-by":"crossref","first-page":"102945","DOI":"10.1016\/j.nantod.2025.102945","volume":"67","author":"K Ma","year":"2026","unstructured":"Ma K, Liu T, Huan W-B et al (2026) Expanding the druggable proteome strategies and innovations in targeted protein degradation. Nano Today 67:102945","journal-title":"Nano Today"},{"issue":"1","key":"842_CR70","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.1038\/s41467-024-54500-x","volume":"15","author":"MF Mabanglo","year":"2024","unstructured":"Mabanglo MF, Wilson B, Noureldin M et al (2024) Crystal structures of DCAF1-PROTAC-WDR5 ternary complexes provide insight into DCAF1 substrate specificity. Nat Commun 15(1):10165","journal-title":"Nat Commun"},{"issue":"6","key":"842_CR71","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/acschembio.0c00285","volume":"15","author":"A Maneiro M","year":"2020","unstructured":"Maneiro M A, Forte N, Shchepinova M M et al (2020) Antibody-PROTAC conjugates enable HER2-dependent targeted protein degradation of BRD4. ACS Chem Biol 15(6):1306\u20131312","journal-title":"ACS Chem Biol"},{"issue":"7930","key":"842_CR72","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-022-05235-6","volume":"610","author":"H Marei","year":"2022","unstructured":"Marei H, Tsai WK, Kee YS et al (2022) Antibody targeting of E3 ubiquitin ligases for receptor degradation. Nature 610(7930):182\u2013189","journal-title":"Nature"},{"issue":"7611","key":"842_CR73","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature18611","volume":"535","author":"ME Matyskiela","year":"2016","unstructured":"Matyskiela ME, Lu G, Ito T et al (2016) A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase. Nature 535(7611):252\u2013257","journal-title":"Nature"},{"issue":"2","key":"842_CR74","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1021\/acs.jmedchem.6b01921","volume":"61","author":"ME Matyskiela","year":"2018","unstructured":"Matyskiela ME, Zhang W, Man HW et al (2018) A cereblon modulator (CC-220) with improved degradation of Ikaros and Aiolos. J Med Chem 61(2):535\u2013542","journal-title":"J Med Chem"},{"issue":"5574","key":"842_CR75","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1126\/science.1073440","volume":"296","author":"JH Min","year":"2002","unstructured":"Min JH, Yang H, Ivan M et al (2002) Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science 296(5574):1886\u20131889","journal-title":"Science"},{"issue":"13","key":"842_CR76","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.cell.2022.05.009","volume":"185","author":"FE Morreale","year":"2022","unstructured":"Morreale FE, Kleine S, Leodolter J et al (2022) BacPROTACs mediate targeted protein degradation in bacteria. Cell 185(13):2338\u201353.e18","journal-title":"Cell"},{"issue":"4","key":"842_CR77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/d41573-019-00043-6","volume":"18","author":"A Mullard","year":"2019","unstructured":"Mullard A (2019) First targeted protein degrader hits the clinic. Nat Rev Drug Discov 18(4):237\u2013239","journal-title":"Nat Rev Drug Discov"},{"key":"842_CR78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ddtec.2018.12.002","volume":"31","author":"M Naito","year":"2019","unstructured":"Naito M, Ohoka N, Shibata N (2019) SNIPERs-Hijacking IAP activity to induce protein degradation. Drug Discov Today Technol 31:35\u201342","journal-title":"Drug Discov Today Technol"},{"issue":"1","key":"842_CR79","first-page":"97","volume":"13","author":"SK Niazi","year":"2025","unstructured":"Niazi SK (2025) Affordable mRNA novel proteins, recombinant protein conversions, and Biosimilars\u2014advice to developers and regulatory agencies. Biomedicine 13(1):97","journal-title":"Biomedicine"},{"issue":"11","key":"842_CR80","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.471","volume":"5","author":"N Ohoka","year":"2014","unstructured":"Ohoka N, Nagai K, Hattori T et al (2014) Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway. Cell Death Dis 5(11):e1513","journal-title":"Cell Death Dis"},{"issue":"12","key":"842_CR81","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1021\/acschembio.9b00704","volume":"14","author":"N Ohoka","year":"2019","unstructured":"Ohoka N, Tsuji G, Shoda T et al (2019) Development of small molecule chimeras that recruit AhR E3 ligase to target proteins. ACS Chem Biol 14(12):2822\u20132832","journal-title":"ACS Chem Biol"},{"issue":"8","key":"842_CR82","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.febslet.2011.03.019","volume":"585","author":"K Okuhira","year":"2011","unstructured":"Okuhira K, Ohoka N, Sai K et al (2011) Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein. FEBS Lett 585(8):1147\u20131152","journal-title":"FEBS Lett"},{"issue":"11","key":"842_CR83","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/cas.12272","volume":"104","author":"K Okuhira","year":"2013","unstructured":"Okuhira K, Demizu Y, Hattori T et al (2013) Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells. Cancer Sci 104(11):1492\u20131498","journal-title":"Cancer Sci"},{"issue":"10","key":"842_CR84","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1021\/acschembio.7b00485","volume":"12","author":"P Ottis","year":"2017","unstructured":"Ottis P, Toure M, Cromm PM et al (2017) Assessing different E3 ligases for small molecule induced protein ubiquitination and degradation. ACS Chem Biol 12(10):2570\u20132578","journal-title":"ACS Chem Biol"},{"issue":"95","key":"842_CR85","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1039\/D1CC05025G","volume":"57","author":"KM Patil","year":"2021","unstructured":"Patil KM, Chin D, Seah HL et al (2021) G4-PROTAC: targeted degradation of a G-quadruplex binding protein. Chem Commun 57(95):12816\u201312819","journal-title":"Chem Commun"},{"issue":"2","key":"842_CR86","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","volume":"17","author":"M Paz Ocaranza","year":"2019","unstructured":"Paz Ocaranza M, Riquelme JA, Garc\u00eda L et al (2019) Counter-regulatory renin\u2013angiotensin system in cardiovascular disease. Nat Rev Cardiol 17(2):116\u2013129","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"842_CR87","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/cmdc.201900497","volume":"15","author":"H Pillow T","year":"2019","unstructured":"Pillow T H, Adhikari P, Blake R A et al (2019) Antibody conjugation of a chimeric BET degrader enables in vivo activity. ChemMedChem 15(1):17\u201325","journal-title":"ChemMedChem"},{"issue":"2","key":"842_CR88","first-page":"461","volume":"11","author":"E Plazas","year":"2023","unstructured":"Plazas E, Faraone N (2023) Indole alkaloids from psychoactive mushrooms: chemical and pharmacological potential as psychotherapeutic agents. Biomedicine 11(2):461","journal-title":"Biomedicine"},{"issue":"26","key":"842_CR89","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.1521738113","volume":"113","author":"K Raina","year":"2016","unstructured":"Raina K, Lu J, Qian Y et al (2016) PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proc Natl Acad Sci USA 113(26):7124\u20137129","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"842_CR90","doi-asserted-by":"crossref","first-page":"eaay5064","DOI":"10.1126\/sciadv.aay5064","volume":"6","author":"M Reynders","year":"2020","unstructured":"Reynders M, Matsuura BS, Berouti M et al (2020) PHOTACs enable optical control of protein degradation. Sci Adv 6(8):eaay5064","journal-title":"Sci Adv"},{"issue":"23","key":"842_CR91","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1002\/cbic.202000351","volume":"21","author":"M Schiedel","year":"2020","unstructured":"Schiedel M, Lehotzky A, Szunyogh S et al (2020) HaloTag-targeted Sirtuin-rearranging ligand (SirReal) for the development of proteolysis-targeting chimeras (PROTACs) against the lysine deacetylase Sirtuin 2 (Sirt2)**. ChemBioChem 21(23):3371\u20133376","journal-title":"ChemBioChem"},{"issue":"12","key":"842_CR92","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1021\/ja039025z","volume":"126","author":"JS Schneekloth Jr","year":"2004","unstructured":"Schneekloth JS Jr, Fonseca FN, Koldobskiy M et al (2004) Chemical genetic control of protein levels: selective in vivo targeted degradation. J Am Chem Soc 126(12):3748\u20133754","journal-title":"J Am Chem Soc"},{"issue":"22","key":"842_CR93","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1016\/j.bmcl.2008.07.114","volume":"18","author":"AR Schneekloth","year":"2008","unstructured":"Schneekloth AR, Pucheault M, Tae HS et al (2008) Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics. Bioorg Med Chem Lett 18(22):5904\u20135908","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"842_CR94","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-58406-0","volume":"16","author":"T Scott","year":"2025","unstructured":"Scott T, Smethurst C a P, Westermaier Y et al (2025) Drugit: crowd-sourcing molecular design of non-peptidic VHL binders. Nat Commun 16(1):3548","journal-title":"Nat Commun"},{"issue":"32","key":"842_CR95","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1039\/D3SC02361C","volume":"14","author":"F Shen","year":"2023","unstructured":"Shen F, Dassama LMK (2023) Opportunities and challenges of protein-based targeted protein degradation. Chem Sci 14(32):8433\u20138447","journal-title":"Chem Sci"},{"issue":"4","key":"842_CR96","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/acssynbio.2c00587","volume":"12","author":"DH Siepe","year":"2023","unstructured":"Siepe DH, Picton LK, Garcia KC (2023) Receptor elimination by E3 ubiquitin ligase recruitment (REULR): a targeted protein degradation toolbox. ACS Synth Biol 12(4):1081\u20131093","journal-title":"ACS Synth Biol"},{"issue":"2","key":"842_CR97","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1021\/acs.jmedchem.7b00675","volume":"61","author":"P Soares","year":"2018","unstructured":"Soares P, Gadd MS, Frost J et al (2018) Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298). J Med Chem 61(2):599\u2013618","journal-title":"J Med Chem"},{"issue":"6","key":"842_CR98","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.cell.2026.01.018","volume":"189","author":"H Song","year":"2026","unstructured":"Song H, Wang W, Mei T et al (2026) Hijacking ERAD for targeted degradation of transmembrane proteins. Cell 189(6):1768\u201384 e24","journal-title":"Cell"},{"issue":"9","key":"842_CR99","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1039\/D2CS00148A","volume":"51","author":"I Sosic","year":"2022","unstructured":"Sosic I, Bricelj A, Steinebach C (2022) E3 ligase ligand chemistries: from building blocks to protein degraders. Chem Soc Rev 51(9):3487\u20133534","journal-title":"Chem Soc Rev"},{"issue":"9","key":"842_CR100","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1021\/acschembio.8b00693","volume":"13","author":"C Steinebach","year":"2018","unstructured":"Steinebach C, Lindner S, Udeshi ND et al (2018) Homo-PROTACs for the chemical knockdown of cereblon. ACS Chem Biol 13(9):2771\u20132782","journal-title":"ACS Chem Biol"},{"issue":"13","key":"842_CR101","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1039\/D0SC00167H","volume":"11","author":"C Steinebach","year":"2020","unstructured":"Steinebach C, Ng YLD, Sosic I et al (2020) Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders. Chem Sci 11(13):3474\u20133486","journal-title":"Chem Sci"},{"issue":"7","key":"842_CR102","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.chembiol.2023.05.010","volume":"30","author":"R Sun","year":"2023","unstructured":"Sun R, Meng Z, Lee H et al (2023) ROTACs leverage signaling-incompetent R-spondin for targeted protein degradation. Cell Chem Biol 30(7):739\u201352 e8","journal-title":"Cell Chem Biol"},{"issue":"40","key":"842_CR103","doi-asserted-by":"crossref","first-page":"27382","DOI":"10.1021\/jacs.4c06402","volume":"146","author":"X Teng","year":"2024","unstructured":"Teng X, Zhao X, Dai Y et al (2024) ClickRNA-PROTAC for tumor-selective protein degradation and targeted cancer therapy. J Am Chem Soc 146(40):27382\u201327391","journal-title":"J Am Chem Soc"},{"issue":"1","key":"842_CR104","doi-asserted-by":"crossref","first-page":"15543","DOI":"10.1038\/s41598-020-72491-9","volume":"10","author":"B Tong","year":"2020","unstructured":"Tong B, Luo M, Xie Y et al (2020) Bardoxolone conjugation enables targeted protein degradation of BRD4. Sci Rep 10(1):15543","journal-title":"Sci Rep"},{"issue":"5","key":"842_CR105","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/acschembio.8b01016","volume":"14","author":"H Tovell","year":"2019","unstructured":"Tovell H, Testa A, Maniaci C et al (2019) Rapid and reversible knockdown of endogenously tagged endosomal proteins via an optimized HaloPROTAC degrader. ACS Chem Biol 14(5):882\u2013892","journal-title":"ACS Chem Biol"},{"issue":"2","key":"842_CR106","volume":"19","author":"SS Usmani","year":"2024","unstructured":"Usmani SS, Wang H, Hao X et al (2024) AbImmPred: an immunogenicity prediction method for therapeutic antibodies using AntiBERTy-based sequence features. PLoS One 19(2):e0296737","journal-title":"PLoS One"},{"issue":"12","key":"842_CR107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105381","volume":"299","author":"D Vandyke","year":"2023","unstructured":"Vandyke D, Xu L, Sargunas PR et al (2023) Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach. J Biol Chem 299(12):105381","journal-title":"J Biol Chem"},{"issue":"42","key":"842_CR108","doi-asserted-by":"crossref","first-page":"16906","DOI":"10.1073\/pnas.1215060109","volume":"109","author":"SM Vogel","year":"2012","unstructured":"Vogel SM, Bauer MR, Joerger AC et al (2012) Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2. Proc Natl Acad Sci USA 109(42):16906\u201316910","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"842_CR109","doi-asserted-by":"crossref","first-page":"107732","DOI":"10.1016\/j.cclet.2022.08.012","volume":"34","author":"J Wang","year":"2023","unstructured":"Wang J, Zhang M, Liu S et al (2023a) Targeting UBE2C for degradation by bioPROTACs based on bacterial E3 ligase. Chin Chem Lett 34(4):107732","journal-title":"Chin Chem Lett"},{"issue":"1","key":"842_CR110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40824-023-00385-8","volume":"27","author":"H Wang","year":"2023","unstructured":"Wang H, Zhou R, Xu F et al (2023b) Beyond canonical PROTAC: biological targeted protein degradation (bioTPD). Biomater Res 27(1):72","journal-title":"Biomater Res"},{"issue":"41","key":"842_CR111","doi-asserted-by":"crossref","first-page":"22855","DOI":"10.1021\/jacs.3c10557","volume":"145","author":"W Wang","year":"2023","unstructured":"Wang W, Zhu C, Zhang B et al (2023c) Correction to \u201cSelf-assembled Nano-PROTAC enables near-infrared photodynamic proteolysis for cancer therapy\u201d. J Am Chem Soc 145(41):22855\u201322856","journal-title":"J Am Chem Soc"},{"issue":"1","key":"842_CR112","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-024-02024-9","volume":"23","author":"C Wang","year":"2024","unstructured":"Wang C, Zhang Y, Chen W et al (2024) New-generation advanced PROTACs as potential therapeutic agents in cancer therapy. Mol Cancer 23(1):110","journal-title":"Mol Cancer"},{"key":"842_CR113","volume":"16","author":"W Wang","year":"2025","unstructured":"Wang W, Aguilar M, Datta S et al (2025a) Dual inhibitor of MDM2 and NFAT1 for experimental therapy of breast cancer: in vitro and in vivo anticancer activities and newly discovered effects on cancer metabolic pathways. Front Pharmacol 16:1531667","journal-title":"Front Pharmacol"},{"key":"842_CR114","doi-asserted-by":"publisher","unstructured":"Wang C, Chen M, Zhang M et al (2025b) Tumour-specific bioorthogonal synthesis of proteolysis-targeting chimeras and nanoparticles boosts T cell activity. Nat Biomed Eng. https:\/\/doi.org\/10.1038\/s41551-025-01560-z","DOI":"10.1038\/s41551-025-01560-z"},{"issue":"11","key":"842_CR115","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1021\/acschembio.8b01083","volume":"14","author":"CC Ward","year":"2019","unstructured":"Ward CC, Kleinman JI, Brittain SM et al (2019) Covalent ligand screening uncovers a RNF4 E3 ligase recruiter for targeted protein degradation applications. ACS Chem Biol 14(11):2430\u20132440","journal-title":"ACS Chem Biol"},{"issue":"10","key":"842_CR116","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1021\/acschembio.4c00191","volume":"19","author":"GE Winter","year":"2024","unstructured":"Winter GE (2024) Extrapolating lessons from targeted protein degradation to other proximity-inducing drugs. ACS Chem Biol 19(10):2089\u20132102","journal-title":"ACS Chem Biol"},{"issue":"15","key":"842_CR117","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1039\/D2CS00116K","volume":"51","author":"J Yamamoto","year":"2022","unstructured":"Yamamoto J, Ito T, Yamaguchi Y et al (2022) Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders. Chem Soc Rev 51(15):6234\u20136250","journal-title":"Chem Soc Rev"},{"issue":"14","key":"842_CR118","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.7150\/thno.59020","volume":"11","author":"S Yan","year":"2021","unstructured":"Yan S, Yan J, Liu D et al (2021) A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity. Theranostics 11(14):6833\u20136846","journal-title":"Theranostics"},{"key":"842_CR119","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113341","volume":"218","author":"X Yang","year":"2021","unstructured":"Yang X, Wang Z, Pei Y et al (2021) Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders. Eur J Med Chem 218:113341","journal-title":"Eur J Med Chem"},{"key":"842_CR120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2020.07.022","volume":"154\u2013155","author":"S Yonezawa","year":"2020","unstructured":"Yonezawa S, Koide H, Asai T (2020) Recent advances in siRNA delivery mediated by lipid-based nanoparticles. Adv Drug Deliv Rev 154\u2013155:64\u201378","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"842_CR121","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","volume":"10","author":"M Zengerle","year":"2015","unstructured":"Zengerle M, Chan KH, Ciulli A (2015) Selective small molecule induced degradation of the BET Bromodomain protein BRD4. ACS Chem Biol 10(8):1770\u20131777","journal-title":"ACS Chem Biol"},{"issue":"1","key":"842_CR122","doi-asserted-by":"crossref","first-page":"10555","DOI":"10.1038\/s41467-025-65590-6","volume":"16","author":"MM Zhan","year":"2025","unstructured":"Zhan MM, Chen H, He M et al (2025) Highly efficient and long-acting split-and-mix proteolysis targeting chimera based on self-assembled polylactic acid. Nat Commun 16(1):10555","journal-title":"Nat Commun"},{"issue":"13","key":"842_CR123","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1039\/C9CS00773C","volume":"49","author":"C Zhang","year":"2020","unstructured":"Zhang C, Pu K (2020) Molecular and nanoengineering approaches towards activatable cancer immunotherapy. Chem Soc Rev 49(13):4234\u20134253","journal-title":"Chem Soc Rev"},{"issue":"7","key":"842_CR124","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41589-019-0279-5","volume":"15","author":"X Zhang","year":"2019","unstructured":"Zhang X, Crowley VM, Wucherpfennig TG et al (2019) Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16. Nat Chem Biol 15(7):737\u2013746","journal-title":"Nat Chem Biol"},{"issue":"40","key":"842_CR125","doi-asserted-by":"crossref","first-page":"16377","DOI":"10.1021\/jacs.1c08521","volume":"143","author":"H Zhang","year":"2021","unstructured":"Zhang H, Han Y, Yang Y et al (2021) Covalently engineered nanobody chimeras for targeted membrane protein degradation. J Am Chem Soc 143(40):16377\u201316382","journal-title":"J Am Chem Soc"},{"issue":"31","key":"842_CR126","doi-asserted-by":"crossref","first-page":"27862","DOI":"10.1021\/jacs.5c07041","volume":"147","author":"W Zhang","year":"2025","unstructured":"Zhang W, Yuan L, Liu R et al (2025) A covalent self-reporting peptide degrader enables real-time monitoring of targeted protein degradation in vivo. J Am Chem Soc 147(31):27862\u201327875","journal-title":"J Am Chem Soc"},{"key":"842_CR127","volume":"10","author":"J Zhao","year":"2022","unstructured":"Zhao J, Tan W, Zheng J et al (2022) Aptamer nanomaterials for ovarian cancer target theranostics. Front Bioeng Biotechnol 10:884405","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"842_CR128","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","volume":"9","author":"G Zhong","year":"2024","unstructured":"Zhong G, Chang X, Xie W et al (2024) Targeted protein degradation: advances in drug discovery and clinical practice. Signal Transduct Target Ther 9(1):308","journal-title":"Signal Transduct Target Ther"}],"container-title":["Handbook of Experimental Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2026_842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:59:27Z","timestamp":1789196367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2026_842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":128,"URL":"https:\/\/doi.org\/10.1007\/164_2026_842","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"13 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}